The PE Ratio as of December 2024 (TTM) for Cardio Diagnostics Holdings, Inc. (CDIO) is -3.40

According to Cardio Diagnostics Holdings, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -3.40. This represents a change of -4.89% compared to the average of -3.57 of the last 4 quarters.

Cardio Diagnostics Holdings, Inc. (CDIO) Historical PE Ratio (quarterly & annually)

How has CDIO PE Ratio performed in the past?

The mean historical PE Ratio of Cardio Diagnostics Holdings, Inc. over the last ten years is -44.32. The current -3.40 PE Ratio has changed 667.15% with respect to the historical average. Over the past ten years (40 quarters), CDIO's PE Ratio was at its highest in in the September 2023 quarter at -0.52. The PE Ratio was at its lowest in in the September 2021 quarter at -67531.44.

Cardio Diagnostics Holdings, Inc. (CDIO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Cardio Diagnostics Holdings, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cardio Diagnostics Holdings, Inc. (CDIO) Average PE Ratio

How has CDIO PE Ratio performed in the past?

The current PE Ratio of Cardio Diagnostics Holdings, Inc. (CDIO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Cardio Diagnostics Holdings, Inc. (CDIO) PE Ratio vs. Peers

How is CDIO’s PE Ratio compared to its peers?

Cardio Diagnostics Holdings, Inc.’s PE Ratio is less than Immix Biopharma, Inc. (-2.82), less than CNS Pharmaceuticals, Inc. (-0.14), less than eFFECTOR Therapeutics, Inc. (-0.00), less than Navidea Biopharmaceuticals, Inc. (0.00), less than Sonnet BioTherapeutics Holdings, Inc. (-0.20), greater than Zura Bio Limited (-4.64), less than Phio Pharmaceuticals Corp. (-0.30), less than 180 Life Sciences Corp. (-0.58), less than Pyxis Oncology, Inc. (0), less than Altamira Therapeutics Ltd. (-1.72), less than Elevation Oncology, Inc. (-0.02), less than ZyVersa Therapeutics, Inc. (-0.80), less than VectivBio Holding AG (-0.00), greater than AVROBIO, Inc. (-7.94), less than null (2.07),

Build a custom stock screener for Cardio Diagnostics Holdings, Inc. (CDIO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cardio Diagnostics Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cardio Diagnostics Holdings, Inc. (CDIO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cardio Diagnostics Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.